The FDA provided guidance on the design of the APOLLO post-marketing confirmatory trial, which will support an accelerated approval filing for bitopertin. Disc plans to submit a New Drug ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback